Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
1.850
+0.020 (1.09%)
Sep 17, 2026, 4:00 PM EDT - Market closed
Compass Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
39
Market Cap
333.16M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 850.00K | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Century Therapeutics | 109.16M |
| Fennec Pharmaceuticals | 59.22M |
| Orchestra BioMed Holdings | 31.98M |
| Zentalis Pharmaceuticals | 26.87M |
| X4 Pharmaceuticals | 15.85M |
| Ocugen | 4.58M |
| EyePoint | 2.79M |
| Palisade Bio | 500.00K |
CMPX News
- 5 weeks ago - Compass Therapeutics price target raised to $7 from $4 at Leerink - TheFly
- 6 weeks ago - Compass Therapeutics Reports 2026 Second Quarter Financial Results and Provides Corporate Update - GlobeNewsWire
- 6 weeks ago - Compass Therapeutics Earnings release: Q2 2026 - Filings
- 6 weeks ago - Compass Therapeutics Quarterly report: Q2 2026 - Filings
- 2 months ago - Compass Therapeutics Announces Tovecimig Data Accepted for an Oral Presentation at the ESMO Congress 2026 - GlobeNewsWire
- 3 months ago - Compass Therapeutics Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 3 months ago - Compass Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 3 months ago - Compass Therapeutics to Participate in Upcoming June Investor Events - GlobeNewsWire